← SynDRA
SAPITINIB
SynDRA canonical compound SYN0037465 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | EGFR | ERBB2 | ERBB3 |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- ERBB3 INHIBITOR
- Receptor tyrosine-protein kinase erbB-3 inhibitor
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
Cross-references
Synonyms
- AZD-8931
- AZD8931
- AZD8931 (Sapitinib)
- Sapitinib(AZD8931)
- UNII-3499328002
- CHEMBL2408045
- 2-(4-((4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-n-methylacetamide
- 2-[4-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidin-1-yl]-N-methylacetamide
- Sapitinib [INN]
- 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-((1-(n-methylcarbamoylmethyl)piperidin-4-yl)oxy)quinazoline
- AZD 8931
- Sapitinib [WHO-DD]
- Sapitinib (AZD-8931)
- AZD-8931(Sapitinib)
- 2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide
- 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-[[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy]quinazoline
- sapitinibum
- Sapitinib (AZD8931)
- MLS006011283
- SCHEMBL202358
- GTPL7717
- DTXSID50233942
- EX-A036
- CHEBI:132986
- BCPP000365
- HMS3655J08
- BCP02835
- BDBM50437353
- MFCD18385011
- NSC758005
- NSC800876
- s2192
- ZINC34587071
- AKOS025404911
- BCP9000357
- CCG-264744
- CS-3951
- DB12183
- NSC-758005
Look up SAPITINIB in the interactive SynDRA portal →